株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国のビタミン産業の分析

China Vitamin Industry Report, 2014-2017

発行 ResearchInChina 商品コード 270637
出版日 ページ情報 英文 117 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
中国のビタミン産業の分析 China Vitamin Industry Report, 2014-2017
出版日: 2014年06月04日 ページ情報: 英文 117 Pages
概要

中国は世界最大のビタミン生産国で、なかでもビタミンCおよびEは重要な製品となっています。2009年以降、海外需要の低迷および価格の下落によって、中国のビタミン生産量は、大きく落ち込みました。2013年の中国における様々なビタミン製品の生産量は、前年比7.4%減少し、およそ20万1千トンとなりました。

当レポートでは、中国のビタミン産業について分析し、世界全体の産業構造・動向や、中国全体および製品分野別の産業動向(生産量・貿易量・価格水準などの実績値・予測値)、主要企業のプロファイル(プロファイル、経営状況、収益構造、主要顧客、ビタミン事業、将来展望・予測)などを調査して、その結果を概略以下の構成でお届けします。

第1章 ビタミンの概要

  • 定義
  • 分類

第2章 中国のビタミン産業の動向

  • 国際市場
  • 現在の発展状況
  • 競争パターン
  • 輸出入
    • 輸出
    • 輸入
  • 今後の見通しと予測

第3章 ビタミン産業:部門別分析

  • ビタミンA
    • 市場動向
    • 輸出入
    • 市場価格
  • ビタミンB
    • D-/DL-パントテン酸(ビタミンB3またはビタミンB5)
    • ビタミンB6
    • ビタミンB1
    • ビタミンB2
    • 塩化コリン(ビタミンB4)
    • ビタミンB12
  • ビタミンC
    • 市場動向
    • 輸出入
    • 市場価格
  • ビタミンE
    • 市場動向
    • 輸出入
    • 市場価格
  • その他

第4章 主要企業

  • DSM
  • BASF
  • Adisseo
  • CSPC Pharmaceutical Group Limited
  • Shandong Xinhua Pharmaceutical
  • North China Pharmaceutical
  • PKU Healthcare
  • Zhejiang Medicine Co., Ltd.
  • Northeast Pharmaceutical
  • Hubei Guangji Pharmaceutical
  • NHU
  • Brother Enterprises Holding
  • Zhejiang Hangzhou Xinfu Pharmaceutical
  • Kingdomway
  • Henan Topfond Pharmaceutical Co.,Ltd
  • Xinfa Pharmaceutical

第5章 予測と見通し

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: QJC008

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total output and vitamin E takes up about 30%. Since 2009, influenced by the sluggish external demand and declining prices, China's output of vitamin products has been declining sharply. In 2013, the output of various types of vitamin products in China was about 201,000 tons, down 7.4% YoY.

China is also the world's largest export base of vitamins, mainly vitamin C, vitamin E and pantothenic calcium. In 2013, China's export volume of vitamin C and vitamin E accounted for 55.0% and 23.7% of total export volume over the same period. In addition, the proportions of D or DL-pantothenic acid (i.e. vitamin B3 or B5) have increased to 5.7%.

Chinese vitamin producers fall into two types: large integrated pharmaceutical enterprises and professional vitamin producers. In 2009-2013, large integrated pharmaceutical enterprises such as North China Pharmaceutical Co.,Ltd and Northeast Pharmaceutical Group Co.,Ltd mostly had heavy burden historically and encountered operating difficulties and development obstacles, thus their ratio of R & D investment in total revenue was less than 3%; while professional vitamin producers like NHU, Kingdomway, and Brother Enterprises Holding kept higher gross margins of their products, with R & D investment generally accounting for more than 4% of revenue.

In recent years, the global and Chinese vitamin market has been exhibiting a monopolistic competition pattern. CSPC Pharmaceutical Group, North China Pharmaceutical, Northeast Pharmaceutical, Aland (Jiangsu) Nutraceutical, Shandong Luwei Pharmaceutical and other Chinese companies with production capacity of more than 15,000 tons, are the major suppliers in the global VC market. Zhejiang Medicine, NHU, and PKU Healthcare together shared about 50% of the global total capacity of VE. NHU, Zhejiang Medicine and Kingdomway three companies together accounted for 40%-50% of the global total capacity of VA.

Since the vitamin industry has high technical barriers, the existing major producers have already formed their own competitive advantages and the cost of quitting is high. So it is estimated that in 2014-2017, the monopolistic competition pattern in China vitamin industry will persist.

image1

"China Vitamin Industry Report, 2014-2017" provided by ResearchInChina covers the following:

  • China vitamin market supply and demand, import and export, competition pattern and development projections;
  • Development status, competition pattern, import and export, market prices of VC, VA, VB, VE products in China;
  • Operation, vitamin business and development prospects of 16 global and Chinese vitamin companies.

Table of Contents

1 Overview of Vitamins

  • 1.1 Definition
  • 1.2 Classification
  • 1.3 Global Overview

2 Development of China Vitamin Industry

  • 2.1 Status Quo
  • 2.2 Import and Export
    • 2.2.1 Export
    • 2.2.2 Import
  • 2.3 Competition Pattern

3 China Vitamin Market Segments

  • 3.1 VA
    • 3.1.1 Development Status
    • 3.1.2 Import and Export
    • 3.1.3 Market Price
  • 3.2 VB
    • 3.2.1 D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5)
    • 3.2.2 VB6
    • 3.2.3 VB1
    • 3.2.4 VB2
    • 3.2.5 Choline Chloride (VB4)
    • 3.2.6 VB12
  • 3.3 VC
    • 3.3.1 Development Status
    • 3.3.2 Import and Export
    • 3.3.3 Market Price
  • 3.4 VE
    • 3.4.1 Development Status
    • 3.4.2 Import and Export
    • 3.4.3 Market Price
  • 3.5 Others

4 Key Enterprises

  • 4.1 DSM
    • 4.1.1 Profile
    • 4.1.2 Operation
    • 4.1.3 Vitamin Business
    • 4.1.4 R&D
    • 4.1.5 Business in China
  • 4.2 BASF
    • 4.2.1 Profile
    • 4.2.2 Operation
    • 4.2.3 Vitamin Business
    • 4.2.4 Business in China
  • 4.3 Adisseo
    • 4.3.1 Profile
    • 4.3.2 Vitamin Business
    • 4.3.2 R & D
  • 4.4 CSPC Pharmaceutical Group Limited
    • 4.4.1 Profile
    • 4.4.2 Operation
    • 4.4.3 Revenue Structure
    • 4.4.4 Vitamin Business
    • 4.4.5 R & D
  • 4.5 Shandong Xinhua Pharmaceutical
    • 4.5.1 Profile
    • 4.5.2 Operation
    • 4.5.3 Revenue Structure
    • 4.5.4 Vitamin Business
    • 4.5.5 R & D
    • 4.5.6 Major Clients
  • 4.6 North China Pharmaceutical
    • 4.6.1 Profile
    • 4.6.2 Operation
    • 4.6.3 Revenue Structure
    • 4.5.4 Vitamin Business
    • 4.6.5 R & D
    • 4.6.6 Major Clients
  • 4.7 PKU Healthcare
    • 4.7.1 Profile
    • 4.7.2 Operation
    • 4.7.3 Revenue Structure
    • 4.7.4 Vitamin Business
    • 4.7.5 R & D
    • 4.7.6 Major Clients
  • 4.8 Zhejiang Medicine Co., Ltd.
    • 4.8.1 Profile
    • 4.8.2 Operation
    • 4.8.3 Revenue Structure
    • 4.8.4 Vitamin Business
    • 4.8.5 R & D
    • 4.8.6 Major Clients
  • 4.9 Northeast Pharmaceutical
    • 4.9.1 Profile
    • 4.9.2 Operation
    • 4.9.3 Revenue Structure
    • 4.9.4 Vitamin Business
    • 4.9.5 R & D
    • 4.9.6 Major Clients
  • 4.10 Hubei Guangji Pharmaceutical
    • 4.10.1 Profile
    • 4.10.2 Operation
    • 4.10.3 Revenue Structure
    • 4.10.4 Vitamin Business
    • 4.10.5 R & D
    • 4.10.6 Major Clients
  • 4.11 NHU
    • 4.11.1Profile
    • 4.11.2 Operation
    • 4.11.3 Revenue Structure
    • 4.11.4 Vitamin Business
    • 4.11.5 R & D
    • 4.11.6 Major Clients
  • 4.12 Brother Enterprises Holding
    • 4.12.1 Profile
    • 4.12.2 Operation
    • 4.12.3 Revenue Structure
    • 4.12.4 Vitamin Business
    • 4.12.5 R & D
    • 4.12.6 Major Clients
  • 4.13 Zhejiang Hangzhou Xinfu Pharmaceutical
    • 4.13.1 Profile
    • 4.13.2 Operation
    • 4.13.3 Revenue Structure
    • 4.13.4 Vitamin Business
    • 4.13.5 R & D
    • 4.13.6Major Clients
  • 4.14 Kingdomway
    • 4.14.1 Profile
    • 4.14.2 Operation
    • 4.14.3 Revenue Structure
    • 4.14.4 R & D
    • 4.14.5 Major Clients
  • 4.15 Henan Topfond Pharmaceutical Co.,Ltd
    • 4.15.1 Profile
    • 4.15.2 Operation
    • 4.15.3 Vitamin Business
    • 4.15.4 R & D
  • 4.16 Xinfa Pharmaceutical
    • 4.16.1 Profile
    • 4.16.2 Operation

5 Forecast and Outlook

  • 5.1 Output and Product Mix
  • 5.2 Competition Pattern

Selected Charts

  • Classification and Effect of Vitamins
  • Global Sales of Vitamin and Mineral Medicine, 2006-2013
  • Global Consumption Structure of Vitamins (by Application)
  • Global Consumption Structure of Major Vitamin Products (by Application)
  • Output of Vitamin Products in China, 2009-2013
  • Output Structure of Vitamin Products in China, 2012
  • China's Export Volume, Export Value and Average Export Price of Vitamins, 2009-2014
  • Structure of China's Vitamin Export Volume, by Product, 2008-2013
  • Export Destinations of China's Vitamins, 2013
  • China's Import Volume, Import Value and Import Average Price of Vitamins, 2010-2014
  • Structure of China's Vitamin Import Volume, by Product, 2008-2013
  • Import Sources of Vitamins in China, 2013
  • Major Vitamin A Enterprises and Their Output in China, 2011-2012
  • China's Export Volume of VA and YoY Growth, 2009-2014
  • China's Export Value of VA and YoY Growth, 2009-2014
  • Export Destinations of China's VA, 2013
  • China's Import Volume of VA and YoY Growth, 2009-2014
  • China's Import Value of VA and YoY Growth, 2009-2014
  • Import Sources of VA in China, 2013
  • Market Prices of VA in China, 2009-2014
  • China's Export Volume, Export Value and Export Average Price of D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5), 2009-2014
  • China's Import Volume, Import Value and Import Average Price of D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5), 2009-2014
  • Market Prices of Calcium Pantothenate (VB5) in China, 2009-2014
  • Market Prices of Niacin (VB3) in China 2009-2014
  • China's Export Volume, Export Value and Export Price of VB6, 2009-2014
  • Market Price of VB6 in China, 2009-2014
  • Output and Export Volume of Major Vitamin B1 Producers in China, 2011-2012
  • China's Export Volume, Export Value and Export Price of VB1, 2009-2014
  • Market Price of VB1 in China, 2009-2014
  • Chinese Major Producers' Output and Export Volume of Vitamin B2 and Its Salts, 2012
  • China's Export Volume, Export Value and Export Price of VB2, 2009-2014
  • Market Prices of VB2 (80%) in China, 2009-2014
  • Structure (%) of China's Choline Chloride Exporting Countries, by Export Volume, 2010-2012
  • Market Prices of Choline Chloride (VB4) in China, 2009-2014
  • China's Export Volume, Export Value and Export Price of VB12, 2009-2014
  • Market Price of VB12 (Liquid Phase 1%) in China, 2009-2013
  • Major Vitamin C Enterprises and Their Output in China, 2012
  • China's Export Volume, Export Value and Export Price of VC, 2009-2014
  • Export Destinations of China's VC , 2013
  • China's Import Volume, Import Value and Import Price of VC, 2009-2014
  • Import Sources of VC in China, 2013
  • Market Price Trends of Coated VC in China, 2009-2014
  • Major VE Enterprises and Their Output in China, 2012
  • China's VE Export Volume and YoY Growth, 2009-2014
  • China's Export Value and Average Price of VE, 2009-2014
  • Export Destinations of China's VE, 2013
  • China's VE Import Volume and YoY Growth, 2009-2014
  • China's Import Value and Import Average Price of VE, 2009-2014
  • Import Sources of VE in China, 2013
  • Market Price Trends of VE in China, 2009-2014
  • China's Output, Export Volume and Growth of Minority Vitamins, 2011-2012
  • Sales and Net Income of DSM, 2009-2014
  • Major Businesses of DSM
  • Sales Structure of DSM, by Business, 2009-2013
  • Sales and EBITDA of DSM's Nutritional Business, 2009-2014
  • R & D Costs and % of Revenue of DSM, 2009-2013
  • DSM's Sales in China, 2009-2013
  • Sales and Net Income of BASF, 2009-2013
  • Sales, EBITDA and % in Revenue of BASF's Performance Products, 2009-2013
  • Sales of Adisseo, 2008-2012
  • Revenue and Net Income of CSPC, 2009-2013
  • Operating Revenue and Profit of CSPC, by Product, 2010-2012
  • Revenue Breakdown of CSPC, by Region, 2010-2013
  • Revenue Structure of CSPC, by Region, 2012-2013
  • CSPC's Output and Export Volume of Vitamins, by Product, 2012
  • CSPC's Revenue of VC Business, 2010-2013
  • Revenue and Net Income of Xinhua Pharmaceutical, 2008-2014
  • Operating Revenue Structure of Xinhua Pharmaceutical, by Product, 2008-2013
  • Revenue of Xinhua Pharmaceutical, by Product, 2008-2013
  • Xinhua Pharmaceutical's Gross Margin of Preparation Products, 2008-2013
  • R & D Costs and % in Revenue of Xinhua Pharmaceutical, 2010-2013
  • Xinhua Pharmaceutical's Revenue from Top 5 Clients and % in Total Revenue, 2008-2013
  • Revenue and Net Income of North China Pharmaceutical, 2008-2014
  • Operating Revenue Structure of North China Pharmaceutical, by Region, 2008-2013
  • Revenue of North China Pharmaceutical, by Region, 2008-2013
  • Operating Revenue Structure of North China Pharmaceutical, by Product, 2009-2013
  • Revenue of North China Pharmaceutical, by Product, 2009-2013
  • North China Pharmaceutical's Subsidiaries Engaging in Vitamin Business
  • North China Pharmaceutical's Output and Export Volume of Some APIs, 2012
  • North China Pharmaceutical's Gross Margin of Vitamin Products, 2008-2013
  • R & D Costs and % in Revenue of North China Pharmaceutical, 2008-2013
  • North China Pharmaceutical's Revenue from Top5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of PKU Healthcare, 2008-2014
  • Operating Revenue Structure of PKU Healthcare, by Region, 2008-2013
  • Revenue of PKU Healthcare, by Region, 2008-2013
  • Operating Revenue Structure of PKU Healthcare, by Sector, 2008-2013
  • Revenue of PKU Healthcare, by Sector, 2008-2013
  • Major Vitamin Products of PKU Healthcare
  • R & D Costs and % in Revenue of PKU Healthcare, 2011-2013
  • North China Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of Zhejiang Medicine, 2009-2014
  • Operating Revenue Structure of Zhejiang Medicine, by Region, 2009-2013
  • Revenue of Zhejiang Medicine, by Region, 2009-2013
  • Operating Revenue Structure of Zhejiang Medicine, by Sector, 2009-2013
  • Revenue of Zhejiang Medicine, by Sector, 2009-2013
  • Zhejiang Medicine's Output and Export Volume of Some APIs, 2012
  • R & D Costs and % in Revenue of Zhejiang Medicine, 2009-2013
  • Zhejiang Medicine's Revenue from Top5 Clients and % of Total Revenue, 2009-2013
  • Revenue and Net Income of Northeast Pharmaceutical, 2009-2014
  • Operating Revenue Structure of Northeast Pharmaceutical, by Region, 2009-2013
  • Revenue of Northeast Pharmaceutical, by Region, 2009-2013
  • Operating Revenue Structure of Northeast Pharmaceutical, by Sector, 2009-2013
  • Revenue of Northeast Pharmaceutical, by Sector, 2009-2013
  • Northeast Pharmaceutical's Output and Export Volume of VC Products, 2011-2012
  • Expenditure for Development Project of Northeast Pharmaceutical, 2010-2013
  • Northeast Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
  • Revenue and Net Income of Guangji Pharmaceutical, 2008-2014
  • Operating Revenue Structure of Guangji Pharmaceutical, by Region, 2008-2013
  • Revenue of Guangji Pharmaceutical, by Region, 2008-2013
  • Operating Revenue Structure of Guangji Pharmaceutical, by Sector, 2008-2013
  • Revenue of Guangji Pharmaceutical, by Sector, 2008-2013
  • Guangji Pharmaceutical's Subsidiaries Engaging in Vitamin Business, 2013
  • Net Income of Guangji Pharmaceutical's Subsidiaries Engaging in Vitamin Business, 2010-2013
  • Guangji Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of NHU, 2008-2014
  • Operating Revenue Structure of NHU, by Region, 2008-2013
  • Revenue of NHU, by Region, 2008-2013
  • Operating Revenue Structure of NHU, by Sector, 2008-2013
  • Revenue of NHU, by Sector, 2008-2011
  • Operating Revenue Structure of NHU, by Sector, 2012-2013
  • Revenue of NHU, by Sector, 2012-2013
  • NHU's Subsidiaries Engaging in Vitamin Business
  • Net Income of NHU's Subsidiaries Engaging in Vitamin Business, 2009-2013
  • NHU's Gross Margin of Vitamin Products, 2008-2011
  • NHU's Gross Margin of Vitamin Products, 2011-2013
  • R & D Costs and % in Revenue of NHU, 2009-2013
  • NHU's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of Brother, 2008-2014
  • Operating Revenue Structure of Brother, by Region, 2008-2013
  • Revenue of Brother, by Region, 2008-2013
  • Operating Revenue Structure of Brother, by Product, 2008-2013
  • Revenue of Brother, by Product, 2008-2013
  • Brother's Gross Margin of Vitamin Products, 2008-2013
  • R & D Costs and % in Revenue of Brother, 2008-2013
  • Brother's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of Xinfu Pharmaceutical, 2009-2014
  • Operating Revenue Structure of Xinfu Pharmaceutical, by Region, 2009-2013
  • Revenue of Xinfu Pharmaceutical, by Region, 2009-2013
  • Operating Revenue Structure of Xinfu Pharmaceutical, by Product, 2009-2013
  • Revenue of Xinfu Pharmaceutical, by Product, 2009-2013
  • Xinfu Pharmaceutical's Gross Margin of Vitamin Products, 2009-2013
  • R & D Costs and % in Revenue of Xinfu Pharmaceutical, 2009-2013
  • Xinfu Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
  • Revenue and Net Income of Kingdomway, 2009-2014
  • Operating Revenue Structure of Kingdomway, by Region, 2009-2013
  • Revenue of Kingdomway, by Region, 2009-2013
  • Operating Revenue Structure of Kingdomway, by Product, 2009-2013
  • Revenue of Kingdomway, by Product, 2009-2013
  • Kingdomway's Gross Margin of Vitamin Related Products, 2009-2013
  • R & D Costs and % in Revenue of Kingdomway, 2009-2013
  • Kingdomway's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
  • Revenue and Net Income of Topfond Pharmaceutical, 2008-2011
  • Xinfa Pharmaceutical's Vitamin Products, Applications and Technical Standards
  • China's Output of Vitamin Products, 2013-2017E

Related Companies

  • China Pharmaceutical Group Limited(01093.HK)
  • Shandong Xinhua Pharmaceutical Company Limited(000756.SZ)
  • North China Pharmaceutical Co.,Ltd.(600812.SH)
  • PKU International Healthcare Group Southwest Pharmaceutical Co., Ltd.(000788.SZ)
  • Zhejiang Medicine Co.,Ltd.(600216.SH)
  • Northeast Pharmaceutical Group Co.,Ltd.(000597.SZ)
  • Hubei Guangji Pharmaceutical Co.,Ltd.(000952.SZ)
  • Zhejiang NHU Company Ltd.(002001.SZ)
  • Brother Enterprises Holding Co.,Ltd(002562.SZ)
  • Zhejiang Hangzhou Xinfu Pharmaceutical Co.,Ltd.(002019.SZ)
  • Xiamen Kingdomway Group Company(002626.SZ)
Back to Top